June 10, 2021 Price forecast | 2 weeks: -3.36% | 1 month: -3.90% | 3 months: -4.70%


PHAT stock forecast

Our latest prediction for Phathom Pharmaceuticals Inc's stock price was made on the June 10, 2021 when the stock price was at 34.92$.

In the short term (2weeks), PHAT's stock price should underperform the market by -3.36%. During that period the price should oscillate between -12.48% and +9.87%.

In the medium term (3months), PHAT's stock price should underperform the market by -4.70%. During that period the price should oscillate between -39.61% and +25.23%.

Create a solid portfolio with PHAT

Add PHAT to your portfolio and optimize it!


About Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -4.22$ per share.

The book value per share is 7.87$

Phathom Pharmaceuticals Inc website


Three months stock forecastJune 10, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -139M - -144M -4.22 - - 34M 7.87 -108M -1M -109M